Francois Lebel

Companies

• Spectrum PharmaceuticalsChief Medical Officer Jun 21, 2019 to Jun 23, 2022¹
• ZIOPHARM OncologyExecutive Vice President R&D Feb 17, 2015 to Jan 3, 2018²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Spectrum Pharmaceuticals SPPI652,016 shares³Jun 23, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 23, 2022Sold 6,667 shares at $0.84 of Spectrum Pharmaceuticals³
• Jun 22, 2022Sold 6,096 shares at $0.81 of Spectrum Pharmaceuticals³
• Jun 21, 2022Granted 405,040 shares of Spectrum Pharmaceuticals³
• Apr 5, 2022Sold 1,367 shares at $1.41 of Spectrum Pharmaceuticals⁴
• Apr 4, 2022Sold 1,205 shares at $1.35 of Spectrum Pharmaceuticals⁴
• Mar 16, 2022Sold 25,105 shares at $0.71 of Spectrum Pharmaceuticals⁵
• Mar 15, 2022Sold 25,130 shares at $0.71 of Spectrum Pharmaceuticals⁵
• Feb 24, 2022Sold 14,708 shares at $0.64 of Spectrum Pharmaceuticals⁶
• Feb 23, 2022Sold 13,466 shares at $0.70 of Spectrum Pharmaceuticals⁶
• Nov 9, 2021Sold 6,000 shares at $2.18 of Spectrum Pharmaceuticals⁷
• Nov 8, 2021Sold 7,363 shares at $2.20 of Spectrum Pharmaceuticals⁷